KemPharm is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.
Ms. Mickle co-founded KemPharm Inc. in 2006 and has held a variety of positions at the company including Vice President and Group Leader, Secretary, Vice President of Corporate Affairs and her current position as Vice President Operations and Product Development.
Since KemPharm’s inception, Ms. Mickle has played an integral part in the start-up and ongoing growth and operations of the company. Today, as Vice President Operations and Product Development, Ms. Mickle oversees the development of each of KemPharm’s products through strategic collaboration across the various drug development disciplines including clinical, regulatory, non-clinical, and manufacturing enabling efficient use of funds and the ability to meet timelines and milestones.
Prior to founding KemPharm, she served as a Research Associate for New River Pharmaceuticals preparing compounds in the areas of ADHD, pain, and thyroid dysfunctions for further study.
Ms. Mickle received her M.A. degree from the University of Virginia and her B.A. and B.S. degrees from Virginia Polytechnic Institute and State University.